Recent News Articles
Ugandan scientist leads research to produce an anti-tick vaccine to combat East Coast Fever
by Admin
In this report, we profile the work of renown Make...
Read MoreThe Safety and Efficacy of the Ticvac Tick Vaccine Against Tick-Borne Diseases in Uganda
by Admin
Prevention of infectious diseases in beef cattle t...
Read MoreHow TicVac-U will turn Ugandas cows into cash cows
by Admin
Ugandan farmers who could switch up their herd to ...
Read MoreThe Persistence of Acaricide Resistance in Ticks in Uganda and the Fight to Address it
by Admin
In the last decade, Uganda has been faced with an ...
Read MoreUnderstanding East Coast Fever–Tickborne Diseases in Uganda
April 3, 2025 at 1:52 pm by Admin
Ticks are among the most important vectors of pathogens that cause some of the most devastating tick-borne diseases (TBDs) in the livestock sector in East, Central and Southern Africa. In Uganda, three tick species are responsible for 90% of cattle's most economically debilitating diseases. The R. appendiculatus tick is the most widely spread of these three. It causes East Coast Fever (ECF), a cattle disease that causes up to 100% mortality in untreated exotic European breeds and their crosses. It is responsible for 30% of the losses in calves of local zebu cattle in Uganda. East Coast Fever remains the most prevalent and economically significant tick-borne disease facing Uganda’s livestock sector, contributing to almost 60 percent of losses in beef production and 48% of losses in milk production. These kinds of losses are not sustainable for either farmers or investment in the livestock sector and the economy. This article provides an in-depth overview of East Coast Fever, its causative agent, regional distribution, clinical signs, as well as new control and preventative measures anticipated to help farmers safeguard their livestock herd, including a look at TicVac-U, the new candidate vaccine for tick-borne East Coast Fever.
Featured
Discover Ticvac-u
The Anti-Tick Vaccine Development Initiative is at the forefront of research to deliver an innovative alternative immunological solution that advances the prevention and treatment of one of Uganda’s most challenging livestock problems: tick-borne diseases. We are the makers of TicVac-U®, a candidate anti-tick vaccine researched, developed and manufactured in Uganda.
Read moreOur Vision
Working together with the Government of Uganda, Makerere University, College of Veterinary Medicine, Animal Resources and Bio-security (COVAB), National Drug Authority (NDA) and other stakeholders, our vision is to eradicate the problems of ticks in Uganda first, then globally, working towards a tick free world.
Our Mission
Our mission is to contribute to the control of ticks and tick-borne diseases by offering innovative alternative immunological control, research, manufacture and distribution of critical veterinary vaccines that will make a positive difference to Uganda’s livestock, the people that depend on them and the country’s economy.
Team
Dr. Margaret Saimo-Kahwa
B.VetMed, Msc, PhD. Principle Investigator, Anti-Tick Vaccine Development Initiative. Senior Lecturer at the College of Veterinary Medicine, Animal Resources and Bio-security (COVAB).
View DetailsDr. Kokas Ikwap
BVM, MSc in Molecular Biology & Biotechnology. Scientist/Parasitologist at the TicVac Anti-Tick Vaccine Development Initiative.
View DetailsDr. William Olaho Mukani
BVM, MSc, PhD in Veterinary Pathology and Microbiology. Dr Olaho is Project Coordinator at IAU-IBAR and a Consultant/Immunologist at the TicVac Anti-Tick Vaccine Development Initiative.
View DetailsDr. David Kalenzi Atuhaire
BVM, MSc, PhD in Veterinary Medicine . Dr. Atuhaire is a Consultant at the TicVac Anti-Tick Vaccine Development Initiative, working on Quality Control protocols for Vaccine Production.
View DetailsDr. Peregrine Sebulime
BVM, Msc, PhD in Biological Sciences. Lecturer, Department of Wildlife and Aquatic Animal Resources, MAK. Scientist at the TicVac Anti-Tick Vaccine Development Initiative.
View DetailsGallery
Our Affiliations



